The University of Delaware, Delaware State University and otherorganizations will receive $25 million over five years from the National Institutes of Health and the state of Delaware to continue research programs that improve patient care and public health.
Officials announced the grant at a ceremony on Friday at the University of Delaware.
Delaware’s Center for Translational Research ACCEL Program will continue its efforts to bolster and expand clinical and translational research in the First State, thanks to the grant renewal from the federal and state agencies.
As part of the renewal, the ACCEL Program grows to five institutions with Delaware State University joining UD, Christiana Care Health System, Nemours/Alfred I. duPont Hospital for Children and the Medical University of South Carolina (MUSC) to support faculty who are interested in research by providing access to needed funding and professional development programs.
“The ACCEL program exists to help promote research that’s important to the health of Delaware and the nation,” said Stuart Binder-Macleod, principal investigator of the ACCEL Program and associate vice president for clinical and translational research at the University of Delaware. “Adding Delaware State University expands the work we are doing to improve health, grow our community engagement efforts and drive economic development in Delaware.”
Click hereto read the full story from UDaily.
A ceremony in the atrium of UD’s Science, Technology and Advanced Research (STAR) Campus celebrated a five-year $25 million renewal of the Delaware Center for Translational Research ACCEL Program, which is funded by the National Institutes of Health and the State of Delaware.